Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)

17.66
Delayed Data
As of Aug 28
 -0.10 / -0.56%
Today’s Change
16.68
Today|||52-Week Range
36.19
-15.66%
Year-to-Date

Today’s Trading

Previous close17.76
Today’s open17.62
Day’s range17.30 - 17.90
Volume587,845
Average volume (3 months)558,724
Market cap$505.4M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+38.36%
Earnings growth (this year)-47.20%
Earnings growth (next 5 years)-15.87%
Revenue growth (last year)+226.23%
P/E ratioNM
Price/Sales3.84
Price/Book3.14

Competitors

 Today’s
change
Today’s
% change
FPRXFive Prime Therapeut...+0.61+3.25%
PFNXPfenex Inc+0.88+4.26%
NDRMNeuroderm Ltd+0.72+3.06%
OVASOvaScience Inc-1.49-6.97%
Data as of 4:14pm ET, 08/28/2015

Financials

Next reporting dateOctober 29, 2015
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$158.4M
Annual profit (last year)-$39.4M
Net profit margin-24.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Independent Director
Sandy D. Smith
Chief Financial Officer
Gregory D. Perry
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers